Clinical Trials

Mission to support patient survival through regenerative therapy and a vision to become the leading company in regenerative therapy in Asia, ProSTEM has conducted in vitro, pre-clinical, clinical, and service-based research to provide scientific evidence of the benefits of stem cells, cells, and their derivatives in regenerative treatment. This research has been carried out in collaboration with researchers from research institutions, educational institutions (such as IPB, Universitas Padjadjaran, Universitas Indonesia, etc.), teaching hospitals (RSCM, RS Sardjito, etc.), as well as private hospitals. Several clinical trials on the use of stem cells and secretomes for degenerative diseases have been conducted by PT Prodia StemCell Indonesia. We have 12 clinical trials registered on clinicaltrials.gov. One of the clinical trials we are currently conducting is for Cerebral Palsy (CP) therapy, where the company collaborates with a leading research team to use Allogeneic Umbilical Cord Mesenchymal Stem Cells (UCMSCs) and Conditioned Media (UCMSCs-CM) to improve physical function and quality of life for children with CP.

Furthermore, PT Prodia StemCell Indonesia is actively involved in clinical trials for various other conditions such as Osteoarthritis, Ischemic Stroke, Liver Cirrhosis (LC) due to Hepatitis B, Retinitis Pigmentosa, and Acute Myocardial Infarction (AMI). The company is committed to gathering solid scientific evidence, involving a team of researchers and medical experts to detail the positive impacts of stem cell use in various medical contexts. The importance of an evidence-based approach is reflected in the focus on therapy efficacy and the involvement of leading research teams, as well as the use of rigorous research methods. Each clinical trial is closely monitored to ensure reliable results and significant contributions to the advancement of medical science. Thus, the clinical trials conducted by this company are not only a crucial step in gathering scientific evidence but also a historic milestone in the evolution of medical treatment.